Rewriting Cancer’s Code: How RIBOTAC Technology Targets TERRA RNA to Stop Tumor Growth

A pioneering molecule built with RIBOTAC technology can seek and destroy TERRA — the RNA molecule that grants cancer cells their immortality

Nov 11, 2025

∙ Paid

A hyper-realistic scientific visualization of a cancer cell being targeted at the molecular level. At the center, a glowing RNA strand labeled “TERRA” is unraveling as a small, precise drug molecule attaches and initiates its breakdown. Surrounding the central scene are faint DNA helices and enzymatic shapes symbolizing RIBOTAC and RNase L activity. The color palette features deep purples, blues, and bright molecular golds to convey innovation and precision. In the background, a blurred microscopic view of cells evokes a cellular battlefield, representing the dismantling of cancer’s immortality at its molecular source. — Image Credit: Microsoft Copilot

For decades, scientists have sought to uncover what gives cancer cells their uncanny ability to evade death. While most cells in the human body have a natural lifespan, cancer cells appear to “forget” when to stop dividing. A new study has now illuminated a key part of this biological mystery, and, for the first time, found a way to dismantle it at the molecular level.

Keep reading with a 7-day free trial

Subscribe to Technicity to keep reading this post and get 7 days of free access to the full post archives.